 PETAH TIKVA, Israel, June 02, 2021 GLOBE NEWSWIRE -- PolyPid Ltd. Nasdaq: PYPD, a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that members of its executive management team will present at three upcoming healthcare investor conferences. 